Roberto Cruz-Gervis is a Respiratory physician. OpenAlex indexes 9 publications with 435 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
125 Parker Hill Ave Ste 502
Roxbury Crossing, MA 021202847
Telephone
617-754-6199Provider last certified this registry record 13 Jul 2021.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- GlaxoSmithKline, LLC.Program year20254 payments
- GENZYME CORPORATIONProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
80.5%Corticosteroid50.3%Trelegy Ellipta33%Breo Ellipta21%Fluticasone Propionate18%Arnuity Ellipta9%Symbicort6%Budesonide-Formoterol Fumarate5%Mometasone Furoate4%Breztri Aerosphere4%Part D<11 patientsbeta2-Adrenergic Agonist14.3%Albuterol Sulfate Hfa84%Ventolin Hfa17%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
9.9%Corticosteroid5.9%Prednisone100%Part D≥11 patientsProton pump inhibitor4%Omeprazole100%Part D<11 patientsAnti-infectives
7.7%Macrolide Antimicrobial7.7%Azithromycin100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Endotoxin-induced acute lung injury requires interaction with the liver
American Journal of Physiology-Lung Cellular and Molecular Physiology
2005 - Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis
Journal of Clinical Microbiology
2003
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”